BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Health Issues HCR

340B Drug Discount Program ---Program Implementation & Oversight ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 4710: 340B Pause Act ---H.R. 5598: 340B Optimization Act Access to Medicines/World Health Organization Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Innovation Act (PAHPAIA) ---H.R. 7328: Pandemic and All-Hazards Preparedness and Innovation Act of 2018 ---National Biodefense Strategy ---Gene Editing Biosimilars ---Access to Samples for Testing ---Coding ---Naming ---Interchangeability and Pharmacy Substitution ---S. 974/H.R. 2212: CREATES Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Patient-Focused Drug Development ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---FDA Management & Financial Accountability ---FDA Hiring Flexibility ---Priority Review Voucher Program ---Regulatory Reform & Modernization ---Use of Real World Evidence Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act ---S.771: Improving Access to Affordable Prescription Drugs ---General Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight ---Drug Shortages ---Supply Chain Integrity and Traceability ---Counterfeiting Drug Pricing ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Funding for Antimicrobial Resistance Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---FY 2020 Labor, HHS, Education Appropriations (Discussion Draft House/Senate) Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---S. 974/H.R. 2212: CREATES Act of 2017 ---H.R. 749: Lower Drug Costs Through Competition Act ---Incentives for Generic Drug Entry ---H.R. 297: Increasing Competition in Pharmaceuticals Act Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculations The United States-Mexico-Canada Agreement ---Pricing and Reimbursement Provisions ---IP Provisions ---Regulatory Harmonization US-UK Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Regulatory Harmonization US-EU Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Regulatory Harmonization US-Japan Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Regulatory Harmonization Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Orphan Drug Issues ---Tax Credit Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Trade and Foreign Drug Price Controls Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education ---Vaccine Quality Measure Diagnostic and Personalized Medicine Regulation and Oversight Precision Medicine Initiative

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Natl Security Council (NSC); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Natl Economic Council (NEC); White House Office; Treasury, Dept of; SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Bills named: S. 637 (115th), H.R. 6378 (115th), H.R. 3219 (115th), S. 1688 (115th), S. 974 (115th), S. 2852 (115th), H.R. 749 (115th), S. 2680 (115th), H.R. 5590 (115th), H.R. 5473 (115th), H.R. 7328 (115th), S. 2665 (115th), H.R. 6 (115th), H.R. 1840 (115th), S. 771 (115th), H.R. 5598 (115th), H.R. 2974 (115th), S. 2669 (115th), S. 2769 (115th), H.R. 4710 (115th), H.R. 2212 (115th), S. 1348 (115th), H.R. 6505 (115th), S. 3158 (115th), H.R. 5806 (115th), H.R. 5002 (115th), S. 1369 (115th), S. 469 (115th), H.R. 297 (115th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Amendment on GE Salmon Labeling Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

Contacted: Agriculture, Dept of (USDA); Natl Economic Council (NEC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; White House Office; Office of Management & Budget (OMB); Treasury, Dept of; U.S. Trade Representative (USTR); Natl Security Council (NSC); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA)

Animals ANI

Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Amendment on GE Salmon Labeling One Health ---S. 2615: Advancing Emergency Preparedness Through One Health Act

Contacted: White House Office; Treasury, Dept of; Food & Drug Administration (FDA); Natl Economic Council (NEC); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE; Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA)

Bills named: S. 2615 (115th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act ---Toomey Amendment to H.R.6147 - Interior, Environment, Financial Services and General Government, Agriculture, Rural Development, Food and Drug Administration, and Transportation, Housing and Urban Development Appropriations Act for FY 2019 Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Biorefineries (non-funding) ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Energy Basic Research Funding ---DOE Office of Science ---Advanced Research Projects Agency-Energy ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---EPA's Issuance of Small Refinery Waivers ---Administratively Extend Reid Vapor Pressure (RVP) relief to E15 ---New Cellulosic Registration Applications Impacting Corn Kernel Fiber ---Proposal to attach RINs to Ethanol Exports ---Renewable Fuel Standard Program: Proposed Standards for 2019 and Biomass-Based Diesel Volume for 2020 ---Shimkus, Flores Draft 21st Century Transportation Fuels Act

Contacted: U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Natl Security Council (NSC); SENATE; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); White House Office; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2005 (115th), S. 3042 (115th), H.R. 4118 (115th), H.R. 2 (115th), H.R. 1311 (115th), S. 2975 (115th), S. 517 (115th), H.R. 5895 (115th), H.R. 6147 (115th)

Small Business SMB

Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act ---S.3614: Corporate Governance Fairness Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act ---S.488: JOBS and Investor Confidence Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017

Contacted: Commerce, Dept of (DOC); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Natl Security Council (NSC); Securities & Exchange Commission (SEC); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); White House Office; Food & Drug Administration (FDA); Treasury, Dept of; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 2126 (115th), S. 3614 (115th), H.R. 4015 (115th), H.R. 10 (115th), S. 488 (115th), S. 791 (115th), H.R. 1645 (115th), H.R. 2655 (115th), H.R. 3978 (115th)

Trade (domestic/foreign) TRD

Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act ---S. 771: Improving Access to Affordable Prescription Drugs ---General Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Japan Biotechnology Regulations ---Like-minded Countries Initiatives Intellectual Property International Enforcement ---Compulsory Licensing ---Chile ---Malaysia ---India The United States-Mexico-Canada Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Ag-Biotech Provisions ---Regulatory Harmonization Trade and Foreign Drug Price Controls Committee on Foreign Investment in the United States (CFIUS) ---Foreign Investment Risk Review Modernization Act (FIRRMA) Implementation ---Export Control Reform Act (ECRA) Implementation US-UK Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Ag-Biotech Provisions ---Regulatory Harmonization US-EU Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Ag-Biotech Provisions ---Regulatory Harmonization US-Japan Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Ag-Biotech Provisions ---Regulatory Harmonization

Contacted: Commerce, Dept of (DOC); White House Office; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE; Patent & Trademark Office (PTO); Natl Economic Council (NEC); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Treasury, Dept of; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: S. 469 (115th), S. 771 (115th)

Agriculture AGR

Agricultural Education Policy Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act EPA Regulations on Biotechnology ---Regulatory Treatment of Gene Edited Products ---Efficient Science-Based Reviews of Biotech Products Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Japan Biotechnology Regulations ---Like-minded Countries Initiatives Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Amendment on GE Salmon Labeling One Health ---S. 2615: Advancing Emergency Preparedness Through One Health Act Potential Regulation of New Genetic Editing/Modification Technologies Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---Potential Revisions to Part 340 Regulations ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---Regulatory Treatment of Gene Editing Products The United States-Mexico-Canada Agreement ---Ag-Biotech Provisions US-UK Trade Agreement ---Ag-Biotech Provisions US-EU Trade Agreement ---Ag-Biotech Provisions US-Japan Trade Agreement ---Ag-Biotech Provisions

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE; Treasury, Dept of; U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Natl Economic Council (NEC); Natl Security Council (NSC); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: S. 3042 (115th), S. 2615 (115th), H.R. 2 (115th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Capital Formation Investment Incentives ---Reform of Net Operating Loss Rules ---H.R. 6756: American Innovation Act of 2018 Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---HR 3149/S. 1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Qualified Small Business Stock (QSBS) Research & Development Tax Credit Reforms ---Expensing of R&D Expenditures ---R&D Payroll Credit Vaccine Injury Compensation Tax ---H.R. 4993/S.3253: Vaccine Access Improvement Act of 2018

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); White House Office; Office of Management & Budget (OMB); Natl Economic Council (NEC); Treasury, Dept of; Natl Security Council (NSC); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1980 (115th), H.R. 4993 (115th), H.R. 3149 (115th), H.R. 6756 (115th), H.R. 4118 (115th), S. 3253 (115th), S. 2005 (115th)

Copyright/Patent/Trademark CPT

Bayh-Dole Act/Tech Transfer ---March-In Rights Intellectual Property International Enforcement ---Compulsory Licensing ---Chile ---Malaysia ---India Inter Partes Review ---Implementation of the America Invents Act of 2011 ---H.R. 5340/S. 1390: STRONGER Patents Act ---H.R. 6264: Restoring America's Leadership Act ---H.R. 7251: Hatch-Waxman Integrity Act of 2018 The United States-Mexico-Canada Agreement ---IP Provisions Patent Reform ---H.R. 5340/S. 1390: STRONGER Patents Act Compulsory Licensing in Federal Programs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 Drug Patent Settlements Patenting of Biological Inventions ---Section 101 Modernization US-UK Trade Agreement ---IP Provisions US-Japan Trade Agreement ---IP Provisions US-EU Trade Agreement ---IP Provisions

Contacted: Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Food & Drug Administration (FDA); White House Office; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC)

Bills named: S. 1390 (115th), H.R. 2655 (115th), H.R. 6505 (115th), H.R. 5340 (115th), H.R. 7251 (115th), H.R. 6264 (115th), S. 791 (115th)

Medicare/Medicaid MMM

Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculation Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Natl Security Council (NSC); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); SENATE; White House Office; Treasury, Dept of

Bills named: S. 771 (115th), S. 1688 (115th), H.R. 6505 (115th)

Budget/Appropriations BUD

Energy Basic Research Funding ---Advanced Research Projects Agency-Energy ---DOE Office of Science ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Antimicrobial Resistance Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---FY 2020 Labor, HHS, Education Appropriations (Discussion Draft House/Senate) Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Renewable Chemicals/Bio-based Products ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---EPA Safer Choice Program Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Contacted: White House Office; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Treasury, Dept of; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Natl Security Council (NSC); Natl Economic Council (NEC)

Bills named: S. 3158 (115th), H.R. 5895 (115th), S. 3042 (115th), H.R. 2 (115th), S. 2975 (115th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---EPA Safer Choice Program Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R. 3149/S.1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S.2005: Master Limited Partnership Parity Act ---S.3296: Sustainable Chemistry Research and Development Act of 208

Contacted: Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); White House Office; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); SENATE; Food & Drug Administration (FDA); Natl Security Council (NSC); Natl Institutes of Health (NIH); Treasury, Dept of; Commerce, Dept of (DOC)

Bills named: S. 1980 (115th), S. 2005 (115th), H.R. 3149 (115th), S. 3296 (115th), S. 3042 (115th), H.R. 2 (115th), H.R. 4118 (115th)

Consumer Issues/Safety/Products CSP

Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act ---S. 771: Improving Access to Affordable Prescription Drugs ---General Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Amendment on GE Salmon Labeling Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

Contacted: Health & Human Services, Dept of (HHS); SENATE; Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); White House Office; Natl Economic Council (NEC); Natl Security Council (NSC); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Bills named: S. 2665 (115th), H.R. 5473 (115th), H.R. 5806 (115th), H.R. 6 (115th), H.R. 5590 (115th), S. 2769 (115th), S. 469 (115th), S. 2669 (115th), S. 771 (115th), S. 2680 (115th), H.R. 5002 (115th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act ---Toomey Amendment to H.R.6147 - Interior, Environment, Financial Services and General Government, Agriculture, Rural Development, Food and Drug Administration, and Transportation, Housing and Urban Development Appropriations Act for FY 2019 Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Biorefineries (non-funding) ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Energy Basic Research Funding ---DOE Office of Science ---Advanced Research Projects Agency-Energy ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---EPA's Issuance of Small Refinery Waivers ---Administratively Extend Reid Vapor Pressure (RVP) relief to E15 ---New Cellulosic Registration Applications Impacting Corn Kernel Fiber ---Proposal to attach RINs to Ethanol Exports ---Renewable Fuel Standard Program: Proposed Standards for 2019 and Biomass-Based Diesel Volume for 2020 ---Shimkus, Flores Draft 21st Century Transportation Fuels Act

Contacted: Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); White House Office; Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Treasury, Dept of; SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Natl Security Council (NSC); Securities & Exchange Commission (SEC)

Bills named: H.R. 2 (115th), H.R. 5895 (115th), S. 2005 (115th), S. 517 (115th), H.R. 1311 (115th), H.R. 6147 (115th), S. 2975 (115th), H.R. 4118 (115th), S. 3042 (115th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA) ---H.R. 7328: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 ---National Biodefense Strategy ---Gene Editing Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---FY 2020 Labor, HHS, Education Appropriations (Discussion Draft House/Senate)

Contacted: Treasury, Dept of; Agriculture, Dept of (USDA); Office of Management & Budget (OMB); SENATE; Natl Security Council (NSC); Natl Economic Council (NEC); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; Securities & Exchange Commission (SEC); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2852 (115th), H.R. 7328 (115th), S. 3158 (115th), H.R. 6378 (115th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA) ---H.R. 7328: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 ---National Biodefense Strategy ---Gene Editing Funding for Antimicrobial Resistance Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---FY 2020 Labor, HHS, Education Appropriations (Discussion Draft House/Senate) Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Contacted: White House Office; Treasury, Dept of; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); SENATE; Securities & Exchange Commission (SEC); Commerce, Dept of (DOC); Natl Security Council (NSC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Bills named: H.R. 7328 (115th), S. 2852 (115th), S. 3158 (115th), H.R. 6378 (115th)